FDA Transparency Plans Raise Investor Disclosure Red Flags
By Eva Temkin, Jane Norberg and Mahnu Davar · September 11, 2025, 5:29 PM EDT
On July 10, the U.S. Food and Drug Administration, as part of what it's calling a push toward "radical transparency" led by U.S. Department of Health and Human Services Secretary Robert F....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login